The Nobel Prize in Chemistry

Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers

LinkedIn Top Startups 2024: The 50 U.S. companies on the rise

Inside the Seattle labs of Xaira, the AI-powered startup launched with $1B from investors

Alumis files for IPO to support work on oral TYK2 blockers